Glucosamine links hyperglycemia to mTORC1 activation and glucose toxicity in diabetes
JCI Insight · 2026
DOI: 10.1172/jci.insight.197331 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Yael Riahi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Unit and Endocrine Service, Hadassah Medical Center, The Hebrew University, Jerusalem, Israel. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Glucosamine, Hyperglycemia, Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Institute of Diabetes and Digestive and Kidney Diseases, The U.S. Department of Veterans Affairs Merit Award, The Israel Science Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Hyperglycemia is a principal driver of β cell failure and multiple-organ complications in diabetes. Chronic exposure to hyperglycemia overstimulates mTORC1, disrupting glucose metabolism and promoting ER stress, oxidative stress, and inflammation; however, the upstream metabolic signal(s) linking glucose to mTORC1 activation remains unclear. Here, we identified glucosamine as a key metabolite connecting elevated glucose to mTORC1 signaling in pancreatic islets and kidney, both major targets of hyperglycemic damage. Using 13 C 6 -glucose metabolic labeling in diabetic rodents treated with or without the SGLT2 inhibitor dapagliflozin or insulin, combined with targeted metabolomics and metabolic flux analysis, we found that tissue glucose concentrations strongly correlated with glucosamine. A similar correlation with plasma glucose was conserved in humans with or without type 2 diabetes, and inversely associated with β cell function. In vitro, low-dose glucosamine stimulated mTORC1 in islets and kidney proximal tubule cells in an O-GlcNAcylation–dependent manner. Broad phosphoproteomics and transcriptomics analyses in β cells showed that glucosamine activated mTORC1-regulating pathways, induced oxidative stress, ER stress, and dedifferentiation. Genetic inhibition of β cell mTORC1 via heterozygous Raptor knockout, as well as pharmacologic inhibition of the glucosamine/mTORC1 axis through SGLT2 inhibition, alleviated β cell stress, improved glycemic control, and restored β cell function. These findings identified the glucosamine/mTORC1 pathway as an important mediator of β cell and kidney dysfunction in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Unit and Endocrine Service, Hadassah Medical Center, The Hebrew University, Jerusalem, Israel.
- The Genomic Applications Laboratory, The Core Research Facility, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
- The Laboratory for Metabolism in Health and Disease, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology Haifa, Israel.
- Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
- Obesity and Metabolism Laboratory, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
- The Azrieli Faculty of Medicine Bar Ilan University, Safed, Israel.
Förderung
- The National Institute of Diabetes and Digestive and Kidney Diseases
- The U.S. Department of Veterans Affairs Merit Award
- The Israel Science Foundation
- The ISF–Juvenile Diabetes Research Foundation
- no
Zitieren
APA
Riahi, Y., Kogot-Levin, A., Teselpapa, Z., Zemelman, E., Gamal, F., Cohen, T., Nasereddin, A., Shiff, I., Abramovich, I., Agranovich, B., Avrahami, D., Hinden, L., Cerasi, E., Kaur, D., Grinberg, L., Piran, R., Tam, J., Bernal-Mizrachi, E., Dror, E., & Leibowitz, G. (2026). Glucosamine links hyperglycemia to mTORC1 activation and glucose toxicity in diabetes. JCI Insight. https://doi.org/10.1172/jci.insight.197331
Vancouver
Riahi Y, Kogot-Levin A, Teselpapa Z, Zemelman E, Gamal F, Cohen T, et al. Glucosamine links hyperglycemia to mTORC1 activation and glucose toxicity in diabetes. JCI Insight. 2026. doi:10.1172/jci.insight.197331
BibTeX
@article{Riahi2026,
author = {Riahi, Yael and Kogot-Levin, Aviram and Teselpapa, Ziv and Zemelman, Elisheva and Gamal, Fatema and Cohen, Tamar and Nasereddin, Abed and Shiff, Idit and Abramovich, Ifat and Agranovich, Bella and Avrahami, Dana and Hinden, Liad and Cerasi, Erol and Kaur, Daljeet and Grinberg, Lihi and Piran, Ron and Tam, Joseph and Bernal-Mizrachi, Ernesto and Dror, Erez and Leibowitz, Gil},
title = {Glucosamine links hyperglycemia to mTORC1 activation and glucose toxicity in diabetes},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.197331}
}
EUVIMED